New York Life Investment Management’s Alexander & Baldwin ALEX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-22,370
Closed -$368K 867
2024
Q1
$368K Buy
22,370
+3,966
+22% +$68.2K ﹤0.01% 1019
2023
Q4
$350K Sell
18,404
-424
-2% -$7.17K ﹤0.01% 1115
2023
Q3
$315K Sell
18,828
-2,967
-14% -$53.8K ﹤0.01% 1109
2023
Q2
$405K Sell
21,795
-4,523
-17% -$84.7K ﹤0.01% 984
2023
Q1
$498K Buy
26,318
+1,855
+8% +$35.2K 0.01% 687
2022
Q4
$458K Buy
24,463
+2,760
+13% +$52.3K 0.01% 980
2022
Q3
$360K Sell
21,703
-19,724
-48% -$363K ﹤0.01% 1022
2022
Q2
$744K Buy
+41,427
New +$853K 0.01% 651

Other funds holding ALEX

New York Life Investment Management's ALEX Position: Q2 2024 in Review

New York Life Investment Management sold out of Alexander & Baldwin (ALEX) in Q2 2024, closing a stake of 22,370 shares — an estimated $368K sold.

New York Life Investment Management first reported a position in ALEX in Q2 2022 and held it in 8 quarters. The position peaked at $744K in Q2 2022. 221 funds tracked by Wall St. Rank hold ALEX as of Q2 2024.

  • New York Life Investment Management reported no remaining Alexander & Baldwin position as of Q2 2024 after selling out during the quarter.
  • New York Life Investment Management sold 22,370 Alexander & Baldwin shares in Q2 2024, an estimated $368K.
  • New York Life Investment Management first reported a position in Alexander & Baldwin in Q2 2022 and held it in 8 quarters.
  • New York Life Investment Management's Alexander & Baldwin position peaked at $744K in Q2 2022.
  • 221 funds tracked by Wall St. Rank held Alexander & Baldwin as of Q2 2024.

Based on New York Life Investment Management's 13F filing for Q2 2024, filed 5 Aug 2024.